Abbott Laboratories (NYSE: ABT) |
|
ABT's Market share relative to its competitors, as of Q1 2025
As of Q1 2025 (Revenue in Millions of $)
Date modified: 2025-06-01T10:35:15+00:00
Select the Relationship:
|
|
Select the Category:
|
|
COMPANY NAME |
REVENUES 12 Months Ending Q1 2025 |
MARKET SHARE 12 Months Q1 2025 |
MARKET SHARE MRQ Q1 2025 |
MARKET SHARE A Quarter Before Q4 2024 |
Abbott Laboratories |
42,344.00 |
4.25% |
4.25 % |
4.30 % |
Johnson and Johnson |
89,331.00 |
8.97% |
8.99% |
8.82% |
Merck and Co Inc |
63,922.00 |
6.42% |
6.37% |
6.12% |
Pfizer Inc |
62,463.00 |
6.27% |
5.63% |
6.96% |
Abbvie Inc |
57,367.00 |
5.76% |
5.48% |
5.92% |
Sanofi |
49,599.72 |
4.98% |
4.98% |
0.00% |
Eli Lilly And Company |
49,003.20 |
4.92% |
5.22% |
5.30% |
Bristol myers Squibb Company |
47,636.00 |
4.78% |
4.60% |
4.84% |
Novartis Ag |
46,660.00 |
4.69% |
4.69% |
0.00% |
Astrazeneca Plc |
45,811.00 |
4.60% |
4.60% |
0.00% |
Thermo Fisher Scientific Inc |
42,898.00 |
4.31% |
4.25% |
4.46% |
Amgen Inc |
33,424.00 |
3.36% |
3.73% |
3.33% |
Medtronic Plc |
33,199.00 |
3.33% |
3.40% |
3.29% |
Takeda Pharmaceutical Company Limited |
29,166.69 |
2.93% |
2.93% |
0.00% |
Gilead Sciences Inc |
28,735.00 |
2.89% |
2.74% |
2.97% |
3m Company |
24,513.00 |
2.46% |
2.44% |
2.35% |
Danaher Corporation |
23,820.00 |
2.39% |
2.36% |
2.56% |
Becton Dickinson And Company |
20,867.00 |
2.10% |
2.16% |
2.02% |
Stryker Corp |
18,449.00 |
1.85% |
2.14% |
1.75% |
Boston Scientific Corporation |
16,747.00 |
1.68% |
1.87% |
1.65% |
Teva Pharmaceutical Industries Limited |
16,617.00 |
1.67% |
1.60% |
1.66% |
Viatris Inc |
14,330.20 |
1.44% |
1.34% |
1.38% |
Dupont De Nemours Inc |
12,521.00 |
1.26% |
1.26% |
1.21% |
Vertex Pharmaceuticals Inc |
11,099.70 |
1.11% |
1.14% |
1.14% |
Biogen Inc |
9,816.40 |
0.99% |
1.00% |
0.96% |
Bausch Health Companies Inc |
9,731.00 |
0.98% |
0.93% |
1.00% |
Baxter International Inc |
9,669.00 |
0.97% |
1.08% |
0.21% |
Alcon inc |
9,455.00 |
0.95% |
0.95% |
0.00% |
Agilent Technologies inc |
6,519.00 |
0.65% |
0.69% |
0.66% |
Organon and Co |
6,294.00 |
0.63% |
0.62% |
0.62% |
Edwards Lifesciences Corporation |
5,253.50 |
0.53% |
0.58% |
0.43% |
Perrigo Company Plc |
4,334.30 |
0.44% |
0.43% |
0.45% |
Dexcom Inc |
4,147.30 |
0.42% |
0.43% |
0.44% |
Fmc Corporation |
4,119.80 |
0.41% |
0.32% |
0.48% |
Jazz Pharmaceuticals Plc |
4,064.81 |
0.41% |
0.37% |
0.43% |
Horizon Therapeutics Public Limited Company |
3,643.45 |
0.37% |
0.39% |
0.33% |
Teleflex Incorporated |
3,009.98 |
0.30% |
0.29% |
0.31% |
Quidelortho Corp |
2,764.70 |
0.28% |
0.28% |
0.28% |
Hologic Inc |
2,673.90 |
0.27% |
0.17% |
0.25% |
Bio rad Laboratories Inc |
2,565.90 |
0.26% |
0.27% |
0.25% |
Royalty Pharma Plc |
2,263.85 |
0.23% |
0.23% |
0.23% |
Insulet Corporation |
2,198.90 |
0.22% |
0.23% |
0.23% |
Masimo Corp |
1,973.70 |
0.20% |
0.15% |
0.24% |
Helen Of Troy Limited |
1,907.41 |
0.19% |
0.20% |
0.21% |
Merit Medical Systems Inc |
1,388.64 |
0.14% |
0.15% |
0.14% |
Livanova Plc |
1,275.26 |
0.13% |
0.13% |
0.13% |
Penumbra Inc |
1,240.10 |
0.12% |
0.13% |
0.12% |
Enact Holdings Inc |
1,216.97 |
0.12% |
0.13% |
0.12% |
Embecta Corp |
1,078.10 |
0.11% |
0.11% |
0.10% |
Tandem Diabetes Care Inc |
982.31 |
0.10% |
0.10% |
0.11% |
Emergent Biosolutions Inc |
965.40 |
0.10% |
0.09% |
0.08% |
Balchem Corp |
964.69 |
0.10% |
0.10% |
0.09% |
Biohaven Ltd |
859.68 |
0.09% |
0.00% |
0.00% |
Shockwave Medical Inc |
787.37 |
0.08% |
0.09% |
0.08% |
Irhythm Technologies Inc |
618.23 |
0.06% |
0.06% |
0.06% |
Taro Pharmaceutical Industries Ltd |
572.95 |
0.06% |
0.06% |
0.00% |
Inari Medical Inc |
572.18 |
0.06% |
0.06% |
0.06% |
Kiniksa Pharmaceuticals International Plc |
481.17 |
0.05% |
0.06% |
0.05% |
Atricure Inc |
478.88 |
0.05% |
0.05% |
0.05% |
Axonics Inc |
430.95 |
0.04% |
0.05% |
0.04% |
Nevro Corp |
407.53 |
0.04% |
0.04% |
0.04% |
Artivion Inc |
389.41 |
0.04% |
0.04% |
0.04% |
Evolus Inc |
380.30 |
0.04% |
0.03% |
0.07% |
Myovant Sciences Ltd |
379.11 |
0.04% |
0.04% |
0.04% |
Mannkind Corporation |
297.60 |
0.03% |
0.03% |
0.03% |
Angiodynamics Inc |
283.00 |
0.03% |
0.03% |
0.03% |
Galapagos Nv |
268.49 |
0.03% |
0.03% |
0.00% |
Revance Therapeutics Inc |
247.00 |
0.02% |
0.02% |
0.03% |
Cardiovascular Systems Inc |
239.84 |
0.02% |
0.03% |
0.02% |
Puma Biotechnology Inc |
232.71 |
0.02% |
0.02% |
0.02% |
Lemaitre Vascular Inc |
225.66 |
0.02% |
0.02% |
0.02% |
Orasure Technologies Inc |
160.62 |
0.02% |
0.01% |
0.02% |
Quanterix Corporation |
134.97 |
0.01% |
0.01% |
0.01% |
Surmodics Inc |
121.58 |
0.01% |
0.01% |
0.01% |
Silk Road Medical Inc |
114.16 |
0.01% |
0.01% |
0.01% |
Rockwell Medical inc |
97.46 |
0.01% |
0.01% |
0.01% |
Meihua International Medical Technologies Co Ltd |
96.20 |
0.01% |
0.01% |
0.00% |
Neuropace Inc |
84.08 |
0.01% |
0.01% |
0.01% |
Owlet Inc |
83.09 |
0.01% |
0.01% |
0.01% |
Cue Health Inc |
70.94 |
0.01% |
0.01% |
0.01% |
Lensar Inc |
57.07 |
0.01% |
0.01% |
0.01% |
Aquestive Therapeutics Inc |
54.23 |
0.01% |
0.00% |
0.00% |
Cvrx inc |
53.12 |
0.01% |
0.01% |
0.01% |
Semler Scientific inc |
49.23 |
0.00% |
0.00% |
0.00% |
Mereo Biopharma Group Plc |
36.46 |
0.00% |
0.00% |
0.00% |
Rapid Micro Biosystems Inc |
29.65 |
0.00% |
0.00% |
0.00% |
Casi Pharmaceuticals inc |
28.54 |
0.00% |
0.00% |
0.00% |
Stereotaxis Inc |
26.59 |
0.00% |
0.00% |
0.00% |
Bicycle Therapeutics Plc |
25.72 |
0.00% |
0.00% |
0.00% |
Allarity Therapeutics Inc |
23.79 |
0.00% |
0.00% |
0.00% |
Senseonics Holdings Inc |
22.70 |
0.00% |
0.00% |
0.00% |
Acutus Medical Inc |
20.01 |
0.00% |
0.00% |
0.00% |
Medicure Inc |
16.78 |
0.00% |
0.00% |
0.00% |
Iterum Therapeutics Plc |
14.32 |
0.00% |
0.00% |
0.00% |
Escalon Medical Corp |
12.17 |
0.00% |
0.00% |
0.00% |
Prophase Labs Inc |
10.12 |
0.00% |
0.00% |
0.00% |
Neuroone Medical Technologies Corp |
6.86 |
0.00% |
0.00% |
0.00% |
Dianthus Therapeutics Inc |
6.52 |
0.00% |
0.00% |
0.00% |
Inspiremd Inc |
6.51 |
0.00% |
0.00% |
0.00% |
Universal Biosensors Inc |
6.09 |
0.00% |
0.00% |
0.00% |
Avinger Inc |
5.83 |
0.00% |
0.00% |
0.00% |
Biomerica Inc |
5.58 |
0.00% |
0.00% |
0.00% |
Lucid Diagnostics Inc |
4.35 |
0.00% |
0.00% |
0.00% |
Co diagnostics Inc |
3.92 |
0.00% |
0.00% |
0.00% |
Elite Health Systems Inc |
3.49 |
0.00% |
0.00% |
0.00% |
Orchestra Biomed Holdings Inc |
2.89 |
0.00% |
0.00% |
0.00% |
Pulse Biosciences Inc |
2.76 |
0.00% |
0.00% |
0.00% |
Neurometrix Inc |
2.68 |
0.00% |
0.00% |
0.00% |
Infinity Pharmaceuticals Inc |
2.57 |
0.00% |
0.00% |
0.00% |
Intelligent Bio Solutions Inc |
2.35 |
0.00% |
0.00% |
0.00% |
Aptinyx Inc |
1.75 |
0.00% |
0.00% |
0.00% |
Immuron Limited |
1.48 |
0.00% |
0.00% |
0.00% |
Therapeuticsmd Inc |
1.41 |
0.00% |
0.00% |
0.00% |
Volitionrx Limited |
1.31 |
0.00% |
0.00% |
0.00% |
Timber Pharmaceuticals Inc |
0.88 |
0.00% |
0.00% |
0.00% |
American Bio Medica Corporation |
0.73 |
0.00% |
0.00% |
0.00% |
Helius Medical Technologies inc |
0.43 |
0.00% |
0.00% |
0.00% |
Catheter Precision Inc |
0.42 |
0.00% |
0.00% |
0.00% |
Guided Therapeutics Inc |
0.16 |
0.00% |
0.00% |
0.00% |
Manhattan Scientifics Inc |
0.14 |
0.00% |
0.00% |
0.00% |
Biosig Technologies Inc |
0.13 |
0.00% |
0.00% |
0.00% |
Sensasure Technologies Inc |
0.12 |
0.00% |
0.00% |
0.00% |
Zivo Bioscience Inc |
0.06 |
0.00% |
0.00% |
0.00% |
Nascent Biotech Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Atyr Pharma Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Ir med Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Heartsciences Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Vivani Medical Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Glucotrack Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Nemaura Medical Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Non Invasive Monitoring Systems Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Movano Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Know Labs Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Point Of Care Nano technology Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Modular Medical Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Adagio Medical Holdings inc |
0.00 |
0.00% |
0.00% |
0.00% |
Autonomix Medical Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Medicinova Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Xtl Biopharmaceuticals Ltd |
0.00 |
0.00% |
0.00% |
0.00% |
Dice Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Ventyx Biosciences Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Azitra Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Acelyrin Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Nexien Biopharma Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Protokinetix Incorporated |
0.00 |
0.00% |
0.00% |
0.00% |
Biophytis Sa |
0.00 |
0.00% |
0.00% |
0.00% |
Galecto Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Protagenic Therapeutics Inc new |
0.00 |
0.00% |
0.00% |
0.00% |
Satsuma Pharmaceuticals Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Connect Biopharma Holdings Limited |
0.00 |
0.00% |
0.00% |
0.01% |
Calcimedica Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Edesa Biotech Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Arrivent Biopharma inc |
0.00 |
0.00% |
0.00% |
0.00% |
Contineum Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Os Therapies Incoporated |
0.00 |
0.00% |
0.00% |
0.00% |
Biostax Corp |
0.00 |
0.00% |
0.00% |
0.00% |
SUBTOTAL |
995,707.94 |
100% |
243,648.34 |
100% |
ABT's Market share relative to its competitors, as of Q1 2025 within the Major Pharmaceutical Preparations Industry
As of Q1 2025
ABT's Market share relative to its competitors, as of Q1 2025 within the Healthcare Sector
As of Q1 2025
Note: Market share is calculated based on total revenue. To get a more accurate picture of Abbott Laboratories's market divisions, geographic dispersion, segments, products, and services, visit Abbott Laboratories's Business Segment. The list includes publicly traded companies only. More information about the sources of this report can be found here.
|